BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1009 related articles for article (PubMed ID: 30299976)

  • 1. In-Clinic Evaluation of the MiniMed 670G System "Suspend Before Low" Feature in Children with Type 1 Diabetes.
    Wood MA; Shulman DI; Forlenza GP; Bode BW; Pinhas-Hamiel O; Buckingham BA; Kaiserman KB; Liljenquist DR; Bailey TS; Shin J; Huang S; Chen X; Cordero TL; Lee SW; Kaufman FR
    Diabetes Technol Ther; 2018 Nov; 20(11):731-737. PubMed ID: 30299976
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of a Predictive Low-Glucose Management System In-Clinic.
    Buckingham BA; Bailey TS; Christiansen M; Garg S; Weinzimer S; Bode B; Anderson SM; Brazg R; Ly TT; Kaufman FR
    Diabetes Technol Ther; 2017 May; 19(5):288-292. PubMed ID: 28221823
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characteristics of Automated Insulin Suspension and Glucose Responses with the Predictive Low-Glucose Management System.
    Abraham MB; Smith GJ; Nicholas JA; Fairchild JM; King BR; Ambler GR; Cameron FJ; Davis EA; Jones TW;
    Diabetes Technol Ther; 2019 Jan; 21(1):28-34. PubMed ID: 30585769
    [TBL] [Abstract][Full Text] [Related]  

  • 4. "Let the Algorithm Do the Work": Reduction of Hypoglycemia Using Sensor-Augmented Pump Therapy with Predictive Insulin Suspension (SmartGuard) in Pediatric Type 1 Diabetes Patients.
    Biester T; Kordonouri O; Holder M; Remus K; Kieninger-Baum D; Wadien T; Danne T
    Diabetes Technol Ther; 2017 Mar; 19(3):173-182. PubMed ID: 28099035
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effectiveness of a Predictive Algorithm in the Prevention of Exercise-Induced Hypoglycemia in Type 1 Diabetes.
    Abraham MB; Davey R; O'Grady MJ; Ly TT; Paramalingam N; Fournier PA; Roy A; Grosman B; Kurtz N; Fairchild JM; King BR; Ambler GR; Cameron F; Jones TW; Davis EA
    Diabetes Technol Ther; 2016 Sep; 18(9):543-50. PubMed ID: 27505305
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Study of MiniMed 640G Insulin Pump with SmartGuard in Prevention of Low Glucose Events in Adults with Type 1 Diabetes (SMILE): Design of a Hypoglycemia Prevention Trial with Continuous Glucose Monitoring Data as Outcomes.
    De Valk HW; Lablanche S; Bosi E; Choudhary P; Silva JD; Castaneda J; Vorrink L; De Portu S; Cohen O
    Diabetes Technol Ther; 2018 Nov; 20(11):758-766. PubMed ID: 30325656
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Predictive Low-Glucose Suspend Reduces Hypoglycemia in Adults, Adolescents, and Children With Type 1 Diabetes in an At-Home Randomized Crossover Study: Results of the PROLOG Trial.
    Forlenza GP; Li Z; Buckingham BA; Pinsker JE; Cengiz E; Wadwa RP; Ekhlaspour L; Church MM; Weinzimer SA; Jost E; Marcal T; Andre C; Carria L; Swanson V; Lum JW; Kollman C; Woodall W; Beck RW
    Diabetes Care; 2018 Oct; 41(10):2155-2161. PubMed ID: 30089663
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reduction in duration of hypoglycemia by automatic suspension of insulin delivery: the in-clinic ASPIRE study.
    Garg S; Brazg RL; Bailey TS; Buckingham BA; Slover RH; Klonoff DC; Shin J; Welsh JB; Kaufman FR
    Diabetes Technol Ther; 2012 Mar; 14(3):205-9. PubMed ID: 22316089
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Switching from Suspend-Before-Low Insulin Pump Technology to a Hybrid Closed-Loop System Improves Glucose Control and Reduces Glucose Variability: A Retrospective Observational Case-Control Study.
    Lepore G; Scaranna C; Corsi A; Dodesini AR; Trevisan R
    Diabetes Technol Ther; 2020 Apr; 22(4):321-325. PubMed ID: 31617752
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prevention of Insulin-Induced Hypoglycemia in Type 1 Diabetes with Predictive Low Glucose Management System.
    Abraham MB; de Bock M; Paramalingam N; O'Grady MJ; Ly TT; George C; Roy A; Spital G; Karula S; Heels K; Gebert R; Fairchild JM; King BR; Ambler GR; Cameron F; Davis EA; Jones TW
    Diabetes Technol Ther; 2016 Jul; 18(7):436-43. PubMed ID: 27148807
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Overnight closed-loop insulin delivery with model predictive control: assessment of hypoglycemia and hyperglycemia risk using simulation studies.
    Wilinska ME; Budiman ES; Taub MB; Elleri D; Allen JM; Acerini CL; Dunger DB; Hovorka R
    J Diabetes Sci Technol; 2009 Sep; 3(5):1109-20. PubMed ID: 20144424
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Retrospective analysis of the real-world use of the threshold suspend feature of sensor-augmented insulin pumps.
    Agrawal P; Zhong A; Welsh JB; Shah R; Kaufman FR
    Diabetes Technol Ther; 2015 May; 17(5):316-9. PubMed ID: 25611577
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reduction in Hypoglycemia With the Predictive Low-Glucose Management System: A Long-term Randomized Controlled Trial in Adolescents With Type 1 Diabetes.
    Abraham MB; Nicholas JA; Smith GJ; Fairchild JM; King BR; Ambler GR; Cameron FJ; Davis EA; Jones TW;
    Diabetes Care; 2018 Feb; 41(2):303-310. PubMed ID: 29191844
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of Sensor-Augmented Pump Therapy with Predictive Low-Glucose Suspend Function on Glycemic Control and Patient Satisfaction in Adults and Children with Type 1 Diabetes.
    Beato-Víbora PI; Quirós-López C; Lázaro-Martín L; Martín-Frías M; Barrio-Castellanos R; Gil-Poch E; Arroyo-Díez FJ; Giménez-Álvarez M
    Diabetes Technol Ther; 2018 Nov; 20(11):738-743. PubMed ID: 30256132
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The PILGRIM study: in silico modeling of a predictive low glucose management system and feasibility in youth with type 1 diabetes during exercise.
    Danne T; Tsioli C; Kordonouri O; Blaesig S; Remus K; Roy A; Keenan B; Lee SW; Kaufman FR
    Diabetes Technol Ther; 2014 Jun; 16(6):338-47. PubMed ID: 24447074
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Safety Evaluation of the MiniMed 670G System in Children 7-13 Years of Age with Type 1 Diabetes.
    Forlenza GP; Pinhas-Hamiel O; Liljenquist DR; Shulman DI; Bailey TS; Bode BW; Wood MA; Buckingham BA; Kaiserman KB; Shin J; Huang S; Lee SW; Kaufman FR
    Diabetes Technol Ther; 2019 Jan; 21(1):11-19. PubMed ID: 30585770
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hypoglycemia Prevention and User Acceptance of an Insulin Pump System with Predictive Low Glucose Management.
    Choudhary P; Olsen BS; Conget I; Welsh JB; Vorrink L; Shin JJ
    Diabetes Technol Ther; 2016 May; 18(5):288-91. PubMed ID: 26907513
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The efficacy and safety of insulin pump therapy with predictive low glucose suspend feature in decreasing hypoglycemia in children with type 1 diabetes mellitus: A systematic review and meta-analysis.
    Alotaibi A; Al Khalifah R; McAssey K
    Pediatr Diabetes; 2020 Nov; 21(7):1256-1267. PubMed ID: 32738022
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reducing Hypoglycemia in the Real World: A Retrospective Analysis of Predictive Low-Glucose Suspend Technology in an Ambulatory Insulin-Dependent Cohort.
    Müller L; Habif S; Leas S; Aronoff-Spencer E
    Diabetes Technol Ther; 2019 Sep; 21(9):478-484. PubMed ID: 31329468
    [No Abstract]   [Full Text] [Related]  

  • 20. Efficacy and Safety of Real-Life Usage of MiniMed 670G Automode in Children with Type 1 Diabetes Less than 7 Years Old.
    Salehi P; Roberts AJ; Kim GJ
    Diabetes Technol Ther; 2019 Aug; 21(8):448-451. PubMed ID: 31166801
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 51.